Abemaciclib
17395
Approved small_molecule terminated
Quick answer
Abemaciclib for Metastatic Breast Cancer is a Approved program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly and Company
- Indication
- Metastatic Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated